RUO supplier
Official terms, laboratory results, and product records reviewed
Deep research review
Stemcode Peptides exposes a detailed public report table naming Freedom Diagnostics and Janoshik Analytical. The site also sells consumer-ready formulations and publishes per-unit product information while its terms restrict products to in-vitro research. That presentation conflict should remain visible.
What this review did not check: The review records a public presentation conflict without making a legal conclusion.
Active storefront observed
The official storefront, catalog, and laboratory-results pages were accessible on the review date.
A functioning site does not establish the exact Wyoming legal entity or facility status.
Findings
Supplier Legal Statement
The terms describe Stemcode as a company registered in Wyoming and restrict products to in-vitro research and education.
Limit: No legal entity number or state registry record was identified on the reviewed page.
Presentation Conflict
The catalog presents ready-to-use nasal sprays, tablets, and topical products with per-unit amounts, ingredients, storage information, and benefit-oriented descriptions while the terms state in-vitro-only use.
Limit: This is an editorial observation, not a legal conclusion.
Public Multi Format Catalog
The public catalog includes vials, nasal sprays, tablets, and topical products.
Limit: Catalog contents and availability can change.
Public Batch Table
The public table exposes product, laboratory, lot, purity or confirmation state, net content, identity, endotoxin when present, report date, and a report link.
Limit: Not every row contains every analytical field.
Public sample report
A GHK-Cu 50 mg vial report for lot GHV0050MG-2601 reports 99.163% purity, 56.58 mg net content, GHK-Cu identity, and an endotoxin pass.
Limit: The result applies only to the listed lot and ordered panel.
Named relationships
named-on-public-table-and-reports
Limit: The exact ISO standard and accreditation scope were not independently verified.
named-on-public-table
Limit: Coverage varies by product and lot.
Search limits
Limited regulatory search
No exact-name FDA warning letter, recall, or enforcement page surfaced in the limited FDA-site search.
Limit: Search absence is not regulatory clearance.
No substantive indexed discussion found
No substantive exact-name Reddit thread surfaced in the indexed search used for this review.
Limit: Search absence is not evidence of reputation.
Open company questions
Observable documentation fields
This measures fields in normalized public records. It does not score product quality, sterility, legal compliance, or suitability.
Normalized batch records
Each row becomes a stacked record on smaller screens. Coverage means the field appears in the source record. It is not a Peptide Report pass or independent reproduction.
| Product | Batch | Laboratory | Date | Methods | Fields present | Record |
|---|---|---|---|---|---|---|
| Tesamorelin 20 mg nasal spray research material | SP26-TEN30 | Freedom Diagnostics Testing | Apr 12, 2026 | HPLC-UV, Mass spectrometry | identity, purity, net Content | Source report |
| GHK-Cu 50 mg research material | GHV0050MG-2601 | Freedom Diagnostics Testing | Mar 23, 2026 | HPLC, LC-MS, Endotoxin | identity, purity, net Content, endotoxin | Source report |
Observed catalog records
The public results table makes report review possible, but its stated 99 percent minimum conflicts with published sub-99 percent results, including a 96.184 percent tesamorelin record.
Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.
These secondary directories helped identify the company. Their rankings and verification labels are not adopted by Peptide Report.